Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1143007

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Parkinson's Disease: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Medicines Usage Reviews have been undertaken for people with Parkinson's in each year since their introduction.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284564
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Since 2014, community pharmacy contractors have been required to conduct 70% of the Medicines Use Reviews (MURs) that they undertake on the following target groups and data is collected accordingly:</p><p>- Patients taking high-risk medicines (Non-steroidal anti-inflammatory drugs, anticoagulants, antiplatelets and diuretics);</p><p>- Patients recently discharged from hospital;</p><p>- Patients prescribed a respiratory drug, as specified; and</p><p>- Patients regularly prescribed four or more medicines, at least one of which is for a risk of cardiovascular disease, as specified.</p><p>Specific data is not collected on the remaining 30% and so it is not possible to say how many people taking medicines for Parkinson’s disease have received an MUR.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 15:14:49 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1143006

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Medicines Usage Reviews have taken place in each year since their introduction.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284562
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>This data has been extracted from the relevant editions of the National Statistics: ‘General Pharmaceutical Services’ for England, which is published on an annual basis by NHS Digital and compares a rolling 10 years data:</p><p> </p><p>2005/06: 148,195</p><p>2006/07: 559,315</p><p>2007/08: 951,358</p><p>2008/09: 1,397,319</p><p>2009/10: 1,707,139</p><p>2010/11: 2,108,604</p><p>2011/12: 2,434,128</p><p>2012/13: 2,820,415</p><p>2013/14: 3,081,108</p><p>2014/15: 3,183,094</p><p>2015/16: 3,313,309</p><p>2016/17: 3,368,005</p><p>2017/18: 3,381,441</p><p>2018/19: Not yet published</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 15:17:11 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1143008

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the impact assessment for Medicines Usage Reviews not being included in the new community pharmacy contract.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284565
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>In line with other measures around releasing sensitive data in internal Impact Assessments, the final Impact Assessment produced in July 2019 in respect of the new Community Pharmacy Contractual Framework, which did include material relating to ending Medicines Usage Reviews, is not being published at this time.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 15:26:16 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1142924

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what alternative arrangements will be introduced in the new local pharmacy contract to safeguard people taking multiple medications and ensure they receive a regular review of their medication to prevent contraindications.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284342
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Medicines Usage Reviews (MURs) are adherence centred reviews with the community pharmacist in isolation from the prescriber. The new Structured Medication Reviews, offered by clinical pharmacists working in primary care networks (PCNs), will provide a more comprehensive review of a patient’s medication with access to the patient record and with the greater ability of clinical pharmacists to make independent decisions to change medication, if that is the result of a review. It is expected that community pharmacists and practice-based pharmacists will work closely together to optimise medicines usage.</p><p>Recently announced changes to the Community Pharmacy Contractual Framework, include a Medicines Reconciliation Service, through which community pharmacists will be expected to collaborate with PCN pharmacists and prescribers, to ensure patients are clear about changes to their medicines, post-discharge, in line with the National Institute for Health and Care Excellence guideline on medicines optimisation. The Pharmacy Quality Scheme and the general practice Quality and Outcomes Framework Quality Improvement modules incentivise PCNs and community pharmacy to identify those taking high risk medicines and take actions to reduce risks where appropriate.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 15:31:26 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1142923

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of scrapping Medicines Usage Reviews on people who take multiple medications.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284398
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 17:30:47 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1142925

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Staff
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure specialist posts such as Parkinson’s nurses are included in the forthcoming NHS workforce plan.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284401
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>I refer the hon. Member to the answers the then Minister of State for Health (Stephen Hammond MP) gave on 4 July 2019 to Questions <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271535/" target="_blank">271535</a> and <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271536/" target="_blank">271536</a>.</p> answering member constituency Kingswood answering member printed Chris Skidmore grouped question UIN 284346 question first answered 09/09/2019 18:54:26 answering member 4021 label Biography information for Chris Skidmore
	tabling member	4126 label Biography information for Mary Glindon

1142926

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Vacancies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps the NHS will take as part of the forthcoming NHS workforce plan to minimise the vacancy rates of (a) Parkinson’s nurses and (b) other specialist posts.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284346
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>I refer the hon. Member to the answers the then Minister of State for Health (Stephen Hammond MP) gave on 4 July 2019 to Questions <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271535/" target="_blank">271535</a> and <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271536/" target="_blank">271536</a>.</p> answering member constituency Kingswood answering member printed Chris Skidmore grouped question UIN 284401 question first answered 09/09/2019 18:54:26 answering member 4021 label Biography information for Chris Skidmore
	tabling member	4126 label Biography information for Mary Glindon